VETERINARY PHARMACEUTICAL TREATMENT

Brand Owner (click to sort) Address Description
ADVASTAT PHARMACIA & UPJOHN COMPANY 100 Route 206 North Peapack NJ 07977 veterinary pharmaceutical for the treatment of cardiovascular diseases;
ELOXIORAL Butler Animal Health Supply 400 Metro Place North Dublin OH 43017 veterinary pharmaceutical for the treatment and management of pain and osteoarthritis;
ENACARD MERIAL 2100 Ronson Road Iselin NJ 08830 veterinary pharmaceutical for the treatment of cardiovascular disease in dogs;
KINEREN ZOETIS SERVICES 10 Sylvan Way Parsippany NJ 07054 VETERINARY PHARMACEUTICAL FOR THE TREATMENT OF RENAL DISEASE IN DOGS AND CATS;
MIRATENSIN MERCK & CO., INC. Rahway NJ veterinary pharmaceutical for the treatment of cardiovascular disease in dogs;
NEPHEREN ZOETIS SERVICES 10 Sylvan Way Parsippany NJ 07054 VETERINARY PHARMACEUTICAL FOR TREATMENT OF RENAL DISEASE IN DOGS AND CATS;
NEPHRESTA ZOETIS SERVICES 10 Sylvan Way Parsippany NJ 07054 VETERINARY PHARMACEUTICAL FOR THE TREATMENT OF RENAL DISEASE IN DOGS AND CATS;
PROXICEF PHARMACIA & UPJOHN COMPANY 100 Route 206 North Peapack NJ 07977 veterinary pharmaceutical for the treatment of bacterial infections;
SIMPLICEF ZOETIS SERVICES 10 Sylvan Way Parsippany NJ 07054 veterinary pharmaceutical for the treatment of bacterial infections;
SOLVION Solvay & Cie. (Societe Anonyme) Rue du Prince Albert 33 B-1050 Brussels Belgium veterinary pharmaceutical for the treatment of degenerative joint disease in large farm animals;
SWINE TECH FARMLAND INDUSTRIES, INC. 12200 N. Ambassador Drive Kansas City MO 64163 veterinary pharmaceutical for the treatment of atrophic rhinitis and pneumonia in swine;SWINE;
 

Where the owner name is not linked, that owner no longer owns the brand

   
Technical Examples
  1. The present disclosure concerns compounds of formula (I) and pharmaceutically acceptable salts, hydrates, solvates, pharmaceutically acceptable derivatives, pro-drugs, tautomers and/or isomers thereof. The disclosure also relates to processes for the preparation of compounds according to formula (I), pharmaceutical or veterinary compositions containing such compounds or methods of treatment and/or prophylaxis of a condition or symptom that is inhibited, reduced or alleviated by opioid receptor activation